Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Nonsteroidal Anti-inflammatory Drug [EPC]
Flurbiprofen is a potent nonsteroidal anti-inflammatory drug (NSAID) of the propionic acid class, primarily utilized to manage pain and inflammation associated with rheumatoid arthritis and osteoarthritis by inhibiting prostaglandin synthesis.
Name
Flurbiprofen
Raw Name
FLURBIPROFEN SODIUM
Category
Nonsteroidal Anti-inflammatory Drug [EPC]
Salt Form
Sodium
Drug Count
4
Variant Count
10
Last Verified
February 17, 2026
RxCUI
1243585, 197724, 389247, 2720355
UNII
Z5B97MU9K4, 5GRO578KLP
About Flurbiprofen
Flurbiprofen is a potent nonsteroidal anti-inflammatory drug (NSAID) of the propionic acid class, primarily utilized to manage pain and inflammation associated with rheumatoid arthritis and osteoarthritis by inhibiting prostaglandin synthesis.
Detailed information about Flurbiprofen
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Flurbiprofen.
Flurbiprofen is a highly potent nonsteroidal anti-inflammatory drug (NSAID) belonging to the propionic acid derivative family, a chemical class it shares with more common medications like ibuprofen and naproxen. Since its initial approval by the U.S. Food and Drug Administration (FDA) in the late 1980s, flurbiprofen has been recognized for its robust analgesic (pain-relieving), anti-inflammatory, and antipyretic (fever-reducing) properties. It is chemically designated as (±)-2-(2-fluoro-4-biphenylyl)propionic acid. Unlike some over-the-counter NSAIDs, flurbiprofen is typically reserved for the management of chronic inflammatory conditions where a more significant degree of prostaglandin inhibition is required.
In clinical practice, flurbiprofen is categorized as a non-selective inhibitor of the cyclooxygenase (COX) enzymes. These enzymes are responsible for the conversion of arachidonic acid into various prostaglandins and thromboxanes—biological mediators that play central roles in the signaling of pain, the development of fever, and the progression of inflammation. By blocking these pathways, flurbiprofen effectively reduces the swelling, stiffness, and joint pain characteristic of degenerative and autoimmune joint diseases.
The therapeutic efficacy of flurbiprofen is rooted in its ability to inhibit the activity of both cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). To understand this at a patient level, one can think of these enzymes as 'factories' that produce chemical messengers called prostaglandins. Prostaglandins are not inherently 'bad'; they protect the stomach lining and support kidney function (primarily via COX-1). However, during injury or chronic disease, the COX-2 enzyme 'factory' ramps up production of specific prostaglandins that sensitize pain receptors and cause tissue inflammation.
Flurbiprofen enters the active site of these enzymes and prevents the substrate (arachidonic acid) from binding. This molecular 'blockade' results in a systemic reduction of prostaglandin levels. While this is excellent for reducing the throbbing pain of rheumatoid arthritis, the simultaneous inhibition of the protective COX-1 enzyme in the gastrointestinal tract is why NSAIDs like flurbiprofen are associated with stomach irritation. The fluorine atom in flurbiprofen's structure enhances its potency compared to its non-fluorinated counterparts, allowing for effective symptom control at lower milligram dosages than some other propionic acid derivatives.
Understanding how the body processes flurbiprofen is essential for optimizing its clinical use and minimizing toxicity.
Flurbiprofen is FDA-approved for several indications centered on musculoskeletal health:
Flurbiprofen is available in several formulations to suit different clinical needs:
> Important: Only your healthcare provider can determine if Flurbiprofen is right for your specific condition. A thorough evaluation of your cardiovascular and gastrointestinal history is required before starting this medication.
Dosage for flurbiprofen must be individualized to the patient's response and clinical needs, always aiming for the lowest effective dose for the shortest duration possible to minimize cardiovascular and gastrointestinal risks. According to the FDA-approved labeling for systemic oral tablets:
The safety and effectiveness of systemic (oral) flurbiprofen in pediatric patients (under the age of 18) have not been established. Clinical trials have not sufficiently evaluated the pharmacokinetic profile or long-term safety in children. Therefore, flurbiprofen is generally not recommended for pediatric use unless specifically directed by a specialist in pediatric rheumatology under close supervision.
Flurbiprofen is primarily eliminated by the kidneys. In patients with mild to moderate renal impairment, a reduction in dosage may be necessary to prevent drug accumulation. For patients with severe renal disease (Creatinine Clearance < 30 mL/min), flurbiprofen is generally not recommended as it may further impair kidney function by reducing protective prostaglandin-mediated blood flow to the renal cortex.
Since the liver is the primary site of metabolism via the CYP2C9 pathway, patients with significant hepatic dysfunction (liver disease) should be started on the lowest possible dose. Monitoring for signs of drug toxicity is essential in this population.
Patients over the age of 65 are at a significantly higher risk for NSAID-induced gastrointestinal bleeding and renal complications. Clinical guidelines suggest starting elderly patients at the lower end of the dosing spectrum (e.g., 100 mg per day in divided doses) and monitoring them closely for occult (hidden) blood loss and changes in blood pressure.
To ensure the best results and minimize side effects, patients should adhere to the following guidelines:
If you miss a dose of flurbiprofen, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular schedule. Never 'double up' on doses to make up for a missed one, as this significantly increases the risk of acute gastrointestinal irritation or toxicity.
Signs of a flurbiprofen overdose may include severe lethargy, drowsiness, nausea, vomiting, and epigastric pain (pain in the upper abdomen). In severe cases, gastrointestinal bleeding, hypertension, acute renal failure, respiratory depression, and coma can occur.
In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Management typically involves symptomatic and supportive care, as there is no specific antidote for flurbiprofen. Gastric lavage or activated charcoal may be administered if the overdose occurred recently (within 1 to 4 hours).
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance, as this could lead to a flare-up of inflammatory symptoms.
As with all NSAIDs, the most frequent adverse reactions associated with flurbiprofen involve the gastrointestinal system. These effects occur because the drug inhibits the COX-1 enzyme, which is responsible for producing the protective mucus lining of the stomach.
> Warning: Stop taking Flurbiprofen and call your doctor or emergency services immediately if you experience any of the following:
Prolonged use of flurbiprofen (months to years) increases the cumulative risk of several conditions:
Flurbiprofen, like all systemic NSAIDs, carries the strictest FDA warning (Black Box Warning) regarding two major risks:
Report any unusual symptoms, especially changes in stool color or persistent stomach pain, to your healthcare provider immediately.
Flurbiprofen is a potent medication that requires careful medical supervision. It is not a simple 'painkiller' and should never be shared with others. Patients must be aware that taking flurbiprofen can mask the symptoms of an underlying infection (like fever or inflammation), potentially delaying proper diagnosis. Additionally, because flurbiprofen can interfere with platelet function, it may increase the time it takes for a wound to stop bleeding.
Cardiovascular Thrombotic Events: Clinical trials of several COX-2 selective and nonselective NSAIDs of up to three years' duration have shown an increased risk of serious cardiovascular (CV) thrombotic events, myocardial infarction, and stroke, which can be fatal. All NSAIDs, both COX-2 selective and nonselective, may have a similar risk. Patients with known CV disease or risk factors for CV disease may be at greater risk. To minimize the potential risk for an adverse CV event in patients treated with flurbiprofen, the lowest effective dose should be used for the shortest duration possible.
Gastrointestinal Bleeding, Ulceration, and Perforation: NSAIDs, including flurbiprofen, can cause serious gastrointestinal (GI) adverse events including inflammation, bleeding, ulceration, and perforation of the stomach, small intestine, or large intestine, which can be fatal. These serious adverse events can occur at any time, with or without warning symptoms, in patients treated with NSAIDs. Only one in five patients who develop a serious upper GI adverse event on NSAID therapy is symptomatic.
Patients on long-term flurbiprofen therapy should undergo periodic laboratory monitoring:
Flurbiprofen may cause dizziness, drowsiness, or visual disturbances in some individuals. Patients should observe how they react to the medication before driving, operating heavy machinery, or engaging in tasks that require mental alertness.
Combining alcohol with flurbiprofen significantly increases the risk of gastrointestinal irritation and bleeding. Patients are strongly advised to avoid or strictly limit alcohol consumption while taking this medication.
While flurbiprofen does not cause a 'withdrawal syndrome' like opioids, stopping it suddenly can lead to a rapid return of arthritis symptoms (pain and stiffness). It is best to discuss a tapering plan with your doctor if you wish to stop the medication.
> Important: Discuss all your medical conditions, especially any history of heart disease, high blood pressure, or stomach ulcers, with your healthcare provider before starting Flurbiprofen.
For each major interaction, the primary management strategy is either to avoid the combination or to perform frequent clinical and laboratory monitoring to ensure patient safety.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete list is vital for preventing dangerous drug-drug interactions.
There are several scenarios where flurbiprofen must NEVER be used because the risks far outweigh any potential benefits:
In these conditions, flurbiprofen should only be used if the healthcare provider determines the benefit justifies the risk, usually at the lowest possible dose:
There is a high degree of cross-sensitivity between flurbiprofen and other NSAIDs. If a patient has had a severe reaction (like swelling of the throat or difficulty breathing) to ibuprofen, naproxen, diclofenac, or celecoxib, they are highly likely to react to flurbiprofen as well. This is known as 'NSAID sensitivity' and is a critical part of a patient's medical history.
> Important: Your healthcare provider will evaluate your complete medical history, including any past reactions to pain medications, before prescribing Flurbiprofen.
The use of flurbiprofen during pregnancy requires extreme caution and is generally discouraged, especially as the pregnancy progresses.
Data from limited studies indicate that flurbiprofen is excreted into human breast milk in very small amounts. The concentration is typically less than 0.1% of the maternal dose. While the risk to the nursing infant is considered low, most healthcare providers recommend caution. If a mother must take flurbiprofen, the infant should be monitored for any signs of gastrointestinal upset or bruising. Alternative analgesics with more extensive safety data in lactation, such as ibuprofen, may be preferred.
As previously noted, flurbiprofen is not approved for systemic use in children under 18. The risk of Reye's syndrome (a rare but serious condition) is associated with aspirin, but because flurbiprofen is in the same general family, caution is exercised. For pediatric arthritis, other NSAIDs with established pediatric dosing (like naproxen or ibuprofen) are the standard of care.
Elderly patients (65 years and older) are at the highest risk for severe complications from flurbiprofen. They are more likely to have age-related decreases in renal function, making them more susceptible to drug accumulation and kidney injury. Furthermore, the risk of 'silent' gastrointestinal bleeds—where the patient has no pain until a major hemorrhage occurs—is significantly higher in this population. Healthcare providers typically start elderly patients on a very low dose and perform frequent blood tests.
In patients with impaired renal function, the half-life of flurbiprofen metabolites may be prolonged. Since prostaglandins are necessary to maintain blood flow to the kidneys in patients with pre-existing renal disease, heart failure, or liver dysfunction, flurbiprofen can precipitate acute renal failure in these individuals. Monitoring of serum creatinine and urine output is mandatory.
Patients with hepatic impairment may have reduced clearance of flurbiprofen. While specific dosing scales (like Child-Pugh) are not always detailed in the labeling, a conservative approach—using 50% of the standard dose—is often employed by clinicians to ensure safety in patients with moderate liver disease.
> Important: Special populations require individualized medical assessment and more frequent monitoring to ensure the safe use of this potent medication.
Flurbiprofen is a non-selective inhibitor of the enzymes cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). At the molecular level, flurbiprofen binds to the hydrophobic channel of the COX enzymes, preventing arachidonic acid from reaching the active site. This stops the conversion of arachidonic acid into prostaglandin G2 (PGG2) and subsequently into other prostaglandins (PGE2, PGI2) and thromboxanes. By reducing the concentration of PGE2 in the joints, flurbiprofen reduces the sensitization of pain fibers (nociceptors) and decreases the recruitment of inflammatory cells, thereby alleviating the symptoms of arthritis.
The pharmacodynamic effect of flurbiprofen is dose-dependent. Higher doses lead to more profound suppression of prostaglandin synthesis. The anti-inflammatory effect usually takes longer to manifest than the analgesic effect; while pain relief may be felt within a few hours of the first dose, the full anti-inflammatory benefit for chronic arthritis may take one to two weeks of consistent dosing to achieve. Unlike opioids, flurbiprofen does not cause physical dependence or tolerance.
| Parameter | Value |
|---|---|
| Bioavailability | ~96% |
| Protein Binding | >99% (primarily to Albumin) |
| Half-life | 5.7 to 6 hours |
| Tmax (Time to Peak) | 1.5 to 2 hours |
| Metabolism | Hepatic (CYP2C9) |
| Excretion | Renal (95% as metabolites) |
Flurbiprofen is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID) and specifically belongs to the propionic acid derivative subclass. It is therapeutically related to other NSAIDs such as naproxen, ibuprofen, and ketoprofen. In the context of its ophthalmic use, it is categorized as an ophthalmic anti-inflammatory agent.
Medications containing this ingredient
Common questions about Flurbiprofen
Flurbiprofen is primarily used to treat the chronic pain, swelling, and joint stiffness caused by rheumatoid arthritis and osteoarthritis. It belongs to the NSAID class of drugs, which work by reducing the production of prostaglandins that cause inflammation in the body. Beyond arthritis, it is sometimes used off-label for severe menstrual cramps or acute gout. In a specialized liquid form, it is also used during eye surgeries like cataract removal to prevent the pupil from constricting. Because it is a potent medication, it is typically used when other over-the-counter options have not provided sufficient relief. Your healthcare provider will determine the best use based on your specific inflammatory condition.
The most common side effects of flurbiprofen involve the digestive system, including indigestion, nausea, stomach pain, and diarrhea. Many patients also report mild headaches or dizziness during the first few days of treatment. Fluid retention, which can cause swelling in the ankles or feet, is another frequent side effect due to the drug's impact on sodium balance. Some people may also experience 'tinnitus,' which is a ringing or buzzing sound in the ears. Most of these symptoms are mild, but if they become persistent or severe, you should contact your doctor. Taking the medication with food can often help reduce the severity of the stomach-related issues.
It is strongly recommended that you avoid or significantly limit alcohol consumption while taking flurbiprofen. Both alcohol and flurbiprofen can irritate the delicate lining of the stomach and intestines. When used together, they significantly increase the risk of developing stomach ulcers or experiencing a dangerous gastrointestinal bleed. Even moderate alcohol intake can worsen the fluid retention and kidney strain sometimes caused by NSAIDs. If you have a history of heavy alcohol use, you must inform your doctor, as flurbiprofen may not be the safest choice for you. Always prioritize your digestive health by keeping these substances separate.
Flurbiprofen is generally not recommended during pregnancy, particularly during the third trimester. Taking flurbiprofen after 30 weeks of pregnancy can cause serious heart and lung problems in the developing fetus, such as the premature closure of the ductus arteriosus. It may also lead to low amniotic fluid levels or complications during labor by delaying contractions. During the first and second trimesters, it should only be used if absolutely necessary and prescribed by a doctor who has weighed the risks. Women who are trying to conceive should also be aware that flurbiprofen can temporarily interfere with ovulation. Always consult your obstetrician before taking any NSAID during pregnancy.
The time it takes for flurbiprofen to work depends on what you are treating. For acute pain relief, such as a headache or menstrual cramps, you may begin to feel the effects within 1 to 2 hours after taking a dose. However, for chronic conditions like rheumatoid arthritis or osteoarthritis, it may take one to two weeks of consistent daily use to reach the full anti-inflammatory benefit. It is important not to stop the medication prematurely if you don't feel immediate relief from joint swelling. Your doctor will likely schedule a follow-up after a few weeks to evaluate how well the drug is working for your specific symptoms. Consistency is key to managing chronic inflammation effectively.
While flurbiprofen is not an addictive medication and does not cause a physical withdrawal syndrome like narcotics, you should not stop taking it suddenly without consulting your doctor. If you are taking it for a chronic condition like arthritis, stopping abruptly can cause a rapid return or 'flare-up' of joint pain, stiffness, and inflammation. If you are experiencing side effects that make you want to stop, your doctor can help you safely taper the dose or switch you to a different medication. For short-term use, such as for a minor injury, stopping is usually fine once the pain has resolved. Always follow the specific plan outlined by your healthcare provider for ending treatment.
If you miss a dose of flurbiprofen, you should take it as soon as you remember. However, if it is nearly time for your next scheduled dose, you should skip the missed dose and simply take the next one at the regular time. Do not take two doses at once to 'catch up,' as this significantly increases the risk of stomach irritation and other side effects. To help you remember your doses, it can be useful to take them at the same time every day, perhaps with a specific meal. If you find yourself frequently forgetting doses, consider using a pill organizer or a smartphone reminder app. Maintaining a steady level of the drug in your system is important for controlling inflammation.
Flurbiprofen does not cause weight gain in the form of increased body fat, but it can cause 'water weight' gain. This happens because NSAIDs can cause the kidneys to retain more sodium and water than usual, leading to edema or swelling in the legs, ankles, and hands. If you notice a sudden, significant increase in weight (such as several pounds in a few days) or visible swelling, you should contact your healthcare provider. This fluid retention can be particularly concerning for patients with a history of heart failure or high blood pressure. In most cases, this weight gain is temporary and will resolve once the medication is discontinued. Monitoring your salt intake may help minimize this effect.
Flurbiprofen can interact with many other medications, so it is vital to provide your doctor with a complete list of everything you take. It should not be taken with other NSAIDs like ibuprofen or naproxen, as this increases the risk of severe stomach and kidney problems. It can also interfere with blood pressure medications (like ACE inhibitors), blood thinners (like warfarin), and certain psychiatric drugs (like lithium). Even common over-the-counter supplements like Ginkgo Biloba can increase the risk of bleeding when combined with flurbiprofen. Your pharmacist is an excellent resource for checking for potential drug interactions. Never start a new medication while taking flurbiprofen without checking with a professional first.
Yes, flurbiprofen is widely available as a generic medication in the form of oral tablets. Generic versions are required by the FDA to have the same active ingredient, strength, dosage form, and route of administration as the original brand-name drug (Ansaid). Choosing the generic version can significantly reduce the cost of your prescription while providing the same therapeutic benefits. Most insurance plans cover generic flurbiprofen as a 'Tier 1' or low-cost medication. You should ensure that the pharmacy provides you with the same generic manufacturer consistently if possible, though all FDA-approved generics are considered bioequivalent. Talk to your pharmacist if you have questions about the appearance of your generic tablets.